{"count":2,"index":{"built_at":"2026-07-27T20:36:23.520789+00:00","public_records":55311,"revision":"6b25e3e9e134a4f06998f2e6"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: ApoB in the context of Wechseljahre"},"results":[{"answer":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL) in the blood and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. During menopause, estrogen decline leads to increased LDL and ApoB levels, along with a shift toward smaller, denser LDL particles – a particularly atherogenic profile. The evidence for ApoB as a risk marker in menopause is solid (prospective cohorts, meta-analyses). However, randomized trials specifically targeting ApoB in postmenopausal women are lacking. Current guidelines (ESC, AHA) recommend ApoB as an alternative or complementary marker, especially in women with metabolic syndrome or diabetes. An ApoB target < 80 mg/dL (or < 65 mg/dL for high risk) is often suggested. MyBody-X tests can measure ApoB, but interpretation requires clinical context. Caveat: No home test replaces a physician's risk assessment. Evidence: human-moderate (strong association, but no RCTs for menopause-specific cutoffs).","area":"gesundheit","canonical_id":"gesundheit:canonical-7dfcad29b2db1f026e1efda9","id":"public-03f01f467a517f852cc05e3f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of Wechseljahre","score":25.25987355,"snippet":"ApoB (apolipoprotein B) is a direct measure of the number of atherogenic particles (LDL, VLDL) in the blood and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. During menopause, estrogen decline leads to increased LDL and ApoB levels, along with a shift toward smaller, denser LDL particles – a particularly atherogenic profile. The evidence for ApoB as a risk marker in menopause is solid (prospective cohorts, meta-analyses). However, randomized trials specifically targeting ApoB in postmenopausal women are lacking. Current guidelines (ESC, AHA) recommend ApoB as an alternative or complementary marker, especially in women with metabolic syndrome or diabete","sources":[],"title":"Evidence check: ApoB in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-03f01f467a517f852cc05e3f/evidence-check-apob-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidence but are not yet universally recommended. The utility is highest when results are interpreted by a clinician and combined with lifestyle factors. Caveat: a single test does not diagnose disease, and over-testing can lead to unnecessary anxiety. Evidence level: practice (established medical practice) with moderate support from guidelines. Sources: none from provided context; general medical consensus.","area":"gesundheit","canonical_id":"gesundheit:canonical-3049975753fbff794ddd57e3","id":"public-0d36aa4284a9d0da95835378","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check useful for Wechseljahre?","score":22.04411483,"snippet":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidenc","sources":[],"title":"Is Cardio Risk Check useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0d36aa4284a9d0da95835378/is-cardio-risk-check-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}